Description:FIELD OF THE INVENTION
The present invention relates to the field of medical imaging and artificial intelligence (AI). More specifically, it pertains to a convolutional neural network (CNN)-based model for the early detection of brain tumors from Magnetic Resonance Imaging (MRI) scans. The invention improves diagnostic accuracy, reduces computational costs, and ensures adaptability for clinical applications, particularly in resource-constrained environments.
BACKGROUND OF THE INVENTION
Early prediction of brain tumors is crucial for effective treatment and better patient prognosis. Deep learning advancements can revolutionize image-based diagnosis in healthcare, using certain or hybrid models that can be deployed in resource-constrained environments. This work proposes a convolutional neural network (CNN)-based model for the prediction of brain tumor from magnetic resonance imaging/MRI scans. The proposed model yields near-perfect performance with 99 % accuracy, sensitivity and precision using balanced dataset and robust preprocessing techniques. The proposed CNN architecture provides high specificity and generalization, and is thus would be appropriate for applications in clinical practice.
Brain tumors are masses of tissues that grow in the brain and can be distinguished as cancerous or non-cancerous. In a year, at least three lacs cases of brain tumors are reported, making them a major cause of worldwide morbidity and mortality [1]. Malignant tumors are commonly known as brain cancer and are always a serious threat to the patient. Malignant tumors are commonly referred to as brain cancer and represent a high risk to a patient. The identification and management of brain tumors therefore depend on certain elements including the type of tumor, its size, spot and stage of development. Brain tumors are among the most life-threatening diseases that affect the human body, and the early diagnosis of these tumors is vital for their removal and the consequent positive results. The central nervous system has the major function of processing signals received from the body and controlling the body’s actions. The main parts include the brainstem, cerebrum and cerebellum are responsible for speech, movement, cognitive ability, memory, and coordination. The cerebral cortex and the brain lobes are structures of the brain with imperative functions, making the brain vulnerable to diseases and disorders. Depending upon the rate of growth and metastasis of the brain tumor, it has four stages to describe its severity. Identification of brain tumors is still a difficult process because tumor tissues are diverse and may look like other healthy brain cells. MRI is an external imaging method, which has become the standard tool for analysing brain tumors as it allows the doctor to have detailed images of the brain to examine and compare with normal scans.
Over the last few years, AI, and more specifically, deep learning, has made a huge impact on the medical imaging, creating new possibilities for improving the diagnostic yield. Using various algorithms brain tumor detection with MRI images could achieved high accuracy rates in automated classification. In this context, applications of artificial intelligence have been emerged in predicting brain tumors based on MRI scans and found to be reliable in spite of the challenges in enhancing the segmentation classification and computational complexity cost. Aljohani et al. used artificial intelligence to solve the problems related to medical imaging and reported improved outcomes [2]. The proposed method was able to detect brain tumors with high-efficiency and precision through the use of CNN, pretrained models, and the Manta Ray Foraging Optimization algorithm on X-ray and MRI data. Their approach could give improved outcome of the pre-trained model by fine-tuning CNN and TL parameters. Preetha et al. intended to develop a new technique that incorporated DCNNs with EfficientNet-B4 model with addition of some layers for the predicting of brain tumors [3]. In particular, their proposed model yielded 99.33% overall accuracy in identifying brain tumors. In another study, Almufareh et al. also used similar architectures of deep learning based to detect brain tumor using MRI images. Their work presented a detailed comparison of two well-known object detection algorithms, YOLOv5, and YOLOv7. The study examined two of the most popular object detection algorithms and used the three variants of brain tumor, namely meningiomas, gliomas, and pituitary adenomas [4]. An investigation by Mathivanan et al. conducted research using four transfer learning frameworks, MobileNetv3, DenseNet169, VGG19, and ResNet152 [5]. The data set used in this work was employed for training and validation of the models that were obtained from the Kaggle platform. Training and testing were done using five-fold cross-validation. To decrease data imbalance and increase model performance, they employed an image enhancement approach to categories related diseases as pituitary, normal, meningioma, and glioma. Among all model, MobileNetV3 was found promising with its accuracy of 99.75%. Similarly, Asiri et al. employed deep machine learning methods for the prediction of brain tumors, including pituitary tumors and meningiomas, and obtained high contrast and classification results [6]. Their approach achieved promising improvements including Dice coefficient of 0.981 with accuracy of 0.989 along with sensitivity and specificity of 0.991. Furthermore, the method exhibited an average processing time of 0.43 S, which is found to be faster compared to other frameworks. These findings revealed higher sensitivity, specificity, accuracy, and Dice similarity coefficient (DSC) than the other methods. In a similar fashion, Aggarwal et al. introduced a solution for the gradient problem in deep neural networks (DNN) by utilizing an improved residual network (ResNet) for the segmentation of brain tumor [7]. Their model improved on the conventional ResNet by either retaining the details of every previous connection link or improving the projection shortcuts. All of these improvements were systematically integrated into the network which allowed the improved ResNet to achieve higher accuracy and faster learning rate. The performance metrics of the adopted method was evaluated with the traditional methods. Fully Convolutional Neural Networks (FCN) using the BRATS 2020 MRI dataset with the proposed method demonstrated 10 % enhanced accuracy compared to others. Sharma et al. presented a technique that improved the segmentation of brain tumor by removing unwanted information from images using GLCM for feature extraction [8]. Using convolutional neural network (CNN), which are widely adopted in biomedical image segmentations, the proposed approach achieved the enhancement of segmentation accuracy compared to previous methods. The proposed method demonstrated excellent performance indices with the mean accuracies of 99.40%, 98.46%, and 98.29%, precisions of 99.41%, 98.51%, and 98.35%, F-scores of were 99.40%, 98.29%, and 98.46% with sensitivities of 99.39%, 98.41%, and 98.25% corresponding to the entire tumor, enhanced tumor, and tumor core, when compared with the existing systems. Similarly, Abdusalomov et al. developed an advanced model based on YOLOv7 for the identification of pituitary gland tumors, gliomas, and meningiomas for an advanced brain tumor detection system [9]. They opted the image enhancement techniques to extract useful information from the MRI scans using filters. However, to enhance the training process with the employed model, data augmentation methods were applied. In another work, Asiri et al. presented an approach for the prediction of brain tumors based on involutional neural networks (InvNets) [10]. While the spatially invariant and channel-specific convolution kernel, the involution kernel was spatially variant and channel invariant. The authors noticed that InvNets surpass the CNNs in terms of performance. With an accuracy of 92%, this method demonstrated its advanced potential for better brain tumor classification. The advantages of InvNets for medical image processing tasks were confirmed by the higher accuracy with fewer parameters compared to their counterparts, especially when the computational power was a constraint. Musallam et al. presented an improved DCNN for the automated diagnosis of pituitary tumors, meningiomas, and gliomas, and a three-stage preprocessing technique to improve the quality of MR images [11]. The architecture used batch normalization to allow for training at a higher speed with a higher learning rate, as well as easily setting the weight of each layer. The proposed architecture was compared and contrasted with the other models. In the experiment, the proposed method was applied to the set of 3,394 MRI scans and yielded overall accuracy of 98.22%, 99% of which were gliomas, 99.13% of meningiomas, 97.3% of pituitary tumors, and 97.14% of normal images. Khan et al. presented deep learning techniques which could yield enhanced classifications without going through the normal step of defining feature extraction manually [12]. Their approach could distinguish between normal and abnormal, as well as meningioma, glioma, and pituitary multiclass brain cancers by applying two deep learning models. In order to solve the classification problem, the they used transfer learning, combining the VGG16 architecture with their proposed architecture of a 23-layer CNN.
Although several studies have been conducted to implement CNN model for the purpose of the detection of the brain tumor, there is still a lack of a solution for issues concerning model reliability issues, its practicability in the clinical practice, and its capacity to detect different types of tumor and variability in MR images. Most of the current models while having high testing accuracy suffer from overfitting problems, limited applicability for external datasets, and high computational cost. The research gap is in the optimization of CNN models by increasing their generalization capacity, reducing computational complexity for practical application and making it more suitable for use in clinical practices. Thus, streamlining of the preprocessing and feature extraction stages and the utilization of more effective methods in MRI images can also be considered as the area that can contribute to the further enhancement of the described model.
SUMMARY OF THE INVENTION
This summary is provided to introduce a selection of concepts, in a simplified format, that are further described in the detailed description of the invention.
This summary is neither intended to identify key or essential inventive concepts of the invention and nor is it intended for determining the scope of the invention.
The invention presents a CNN-based deep learning model designed for early detection and classification of brain tumors using MRI scans. The model achieves near-perfect accuracy of 99% through a combination of robust data preprocessing, optimized CNN architecture, and advanced classification techniques.
The proposed system utilizes a structured dataset comprising 4,600 MRI images labeled as healthy or tumor-affected. Preprocessing techniques, including image resizing, intensity normalization, and data augmentation, ensure consistency and improve model robustness. The CNN architecture consists of multiple convolutional layers for feature extraction, pooling layers for dimensionality reduction, and fully connected layers for classification.
The training pipeline employs a 70:20:10 data split for training, validation, and testing, ensuring a well-balanced evaluation of model performance. Advanced training strategies, including early stopping and dropout regularization, prevent overfitting and enhance generalization across different MRI datasets.
To improve model interpretability, the system incorporates feature visualization techniques such as heatmaps and activation maps. These visualizations help highlight tumor-specific regions, aiding radiologists in verifying AI-based predictions. Performance evaluation metrics, including Receiver Operating Characteristic (ROC) curves and confusion matrices, demonstrate the model’s superiority in sensitivity, specificity, and precision.
Unlike conventional CNN models, the proposed system is designed for real-time clinical integration. Its computational efficiency allows for deployment in hospitals, diagnostic centers, and telemedicine platforms, bridging the gap between AI advancements and real-world medical applications.
To further clarify advantages and features of the present invention, a more particular description of the invention will be rendered by reference to specific embodiments thereof, which is illustrated in the appended drawings. It is appreciated that these drawings depict only typical embodiments of the invention and are therefore not to be considered limiting of its scope. The invention will be described and explained with additional specificity and detail with the accompanying drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
The illustrated embodiments of the subject matter will be understood by reference to the drawings, wherein like parts are designated by like numerals throughout. The following description is intended only by way of example, and simply illustrates certain selected embodiments of devices, systems, and methods that are consistent with the subject matter as claimed herein, wherein:
Figure 1. Workflow of the Proposed Model.
Figure 2. CNN Architecture
Figure 3. Visualization of convolution feature mapping of different convolution layers
Figure 4. Training and Validation Accuracy, Fig.(left) and Training and Validation Loss, Fig.(right) of the Proposed Model
Figure 5. Receiver Operating Characteristic Curve (ROC)
Figure 6. Confusion Matrix Heatmap
Figure 7. Class Distribution
Figure 8. Performance Metrics Across Configurations
The figures depict embodiments of the present subject matter for the purposes of illustration only. A person skilled in the art will easily recognize from the following description that alternative embodiments of the structures and methods illustrated herein may be employed without departing from the principles of the disclosure described herein.
DETAILED DESCRIPTION OF THE INVENTION
The detailed description of various exemplary embodiments of the disclosure is described herein with reference to the accompanying drawings. It should be noted that the embodiments are described herein in such details as to clearly communicate the disclosure. However, the amount of details provided herein is not intended to limit the anticipated variations of embodiments; on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the scope of the present disclosure as defined by the appended claims.
It is also to be understood that various arrangements may be devised that, although not explicitly described or shown herein, embody the principles of the present disclosure. Moreover, all statements herein reciting principles, aspects, and embodiments of the present disclosure, as well as specific examples, are intended to encompass equivalents thereof.
The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of example embodiments. As used herein, the singular forms “a",” “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises,” “comprising,” “includes” and/or “including,” when used herein, specify the presence of stated features, integers, steps, operations, elements and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components and/or groups thereof.
It should also be noted that in some alternative implementations, the functions/acts noted may occur out of the order noted in the figures. For example, two figures shown in succession may, in fact, be executed concurrently or may sometimes be executed in the reverse order, depending upon the functionality/acts involved.
In addition, the descriptions of "first", "second", “third”, and the like in the present invention are used for the purpose of description only, and are not to be construed as indicating or implying their relative importance or implicitly indicating the number of technical features indicated. Thus, features defining "first" and "second" may include at least one of the features, either explicitly or implicitly.
Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which example embodiments belong. It will be further understood that terms, e.g., those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
I. The invention comprises an end-to-end deep learning-based diagnostic system that processes MRI scans to detect brain tumors. The system includes multiple components: a preprocessing module, CNN architecture, training pipeline, visualization tools, and a clinical integration framework.
The dataset consists of 4,600 MRI images, categorized into healthy and tumor-affected samples. To enhance model robustness, images are resized to a uniform 256 × 256 pixels, intensity values are normalized to a 0-1 scale, and segmentation techniques are applied to isolate brain tissue. Data augmentation, including rotation, flipping, and brightness modulation, mitigates overfitting and enhances generalization.
The CNN architecture follows a hierarchical structure. The input layer processes MRI scans, feeding them into convolutional layers that extract spatial patterns. Pooling layers reduce dimensionality while preserving key features. Fully connected layers further refine classification decisions, outputting predictions of either tumor presence or absence.
The training and validation phase employs TensorFlow and Keras frameworks, utilizing GPU acceleration for computational efficiency. Hyperparameter tuning optimizes learning rates, dropout rates, and batch sizes. A combination of categorical cross-entropy loss and Adam optimizer ensures stable convergence.
To assess performance, the model undergoes extensive validation using metrics such as accuracy, precision, recall, and F1-score. ROC curve analysis quantifies classification reliability, while confusion matrices visualize prediction accuracy. The system consistently achieves an accuracy of 99%, demonstrating its effectiveness in distinguishing between healthy and tumor-affected MRI scans.
Feature visualization techniques, including Grad-CAM and saliency maps, enhance model transparency by highlighting regions of interest within MRI scans. This interpretability component aids radiologists in validating AI-generated predictions, fostering trust in AI-assisted diagnostics.
The clinical integration framework supports real-time deployment through an intuitive user interface. Radiologists and medical professionals can upload MRI scans, receive AI-based predictions, and visualize highlighted tumor regions. The system is designed for seamless interoperability with existing hospital information systems (HIS) and Picture Archiving and Communication Systems (PACS).
By combining high accuracy, computational efficiency, and explainability, the proposed invention provides a groundbreaking solution for early brain tumor detection. The system's adaptability ensures applicability in both high-resource hospitals and low-resource medical settings, expanding access to advanced diagnostic tools.
II. Materials & Methods
Figure 1 outlines the workflow for CNN-based brain tumor detection approach which includes, Dataset Selection, Data Preprocessing, CNN Architecture, Training and Validation and Testing & External Validation, which are further explored below.
1. Dataset Selection
In this work, the dataset from Kaggle was used which included 4,600 MRI images labeled as healthy and tumor samples. The use of images from axial, coronal and sagittal planes in the dataset enhances the performance of the model especially when exposed to different data.
This dataset was chosen for its large size, which is vital when it comes to training and testing deep learning models. For a balanced distribution of classes, it was split into training, validation, and testing data sets in a ratio of 7:2:1. This approach allows to develop, optimize and evaluate the performance of the adopted model.
2. Data Preprocessing
To ensure the uniformity in the data set, and improving the quality, all the photos were sized to a uniform 256 × 256 pixels. Further, min-max normalization was used to account for the variation in pixel intensity due to acquisition techniques as pixel intensity values were of 0-1. Data has been pre-processed by segmenting the images in such a way as to make them only display the brain tissues by removing other parts of the image that were not of interest. Overfitting was prevented by data augmentation techniques such as flip, rotation and brightness modulation of images.
3. Model Architecture
CNN model was opted for the binary classification of brain tumor. An architecture of CNN used for image classification is shown in Figure 2. It begins with an Input Layer to get the image data, and a Convolutional Layer that extracts important features using filters. Max Pooling Layer decreases spatial dimensions without losing the valuable features, while controlling complexity. Then, a set of extracted features is fed into the Dense Layer which identifies patterns and learns where the patterns are likely to occur (or not) and finally output that the Output Layer gives the classification results. This streamlined flow allows efficient feature filtration and correct prediction. CNNs are capable of learning spatial features from MRI scans, they are revolutionizing the identification of brain tumors by removing the need for manual feature engineering. Frequently outperforming conventional techniques, these networks classify tumor-affected and healthy brain areas with high accuracy. By managing the variations in tumor appearance, size, shape, and intensity among patients and imaging methods, CNNs gives accurate results in the identification of tumor. Their versatility includes the ability to differentiate between different types of tumors using both binary classification (tumor vs. healthy) and multi-class classification.
Furthermore, CNN perform exceptionally well on segmentation tasks, which allows for accurate tumor boundary location. By incorporating preprocessing methods such as augmentation and normalization, CNN increase MRI image robustness to noise and artifacts. Their capacity to generalize across datasets guarantees adaptation to various imaging settings, and their scalability makes them appropriate for huge datasets, allowing population-scale screenings. CNN offer trustworthy second views in clinical workflows, helping radiologists prioritize patients and improving the time and accuracy of decision making. Additionally, CNN models may be able to learn continuously, which would enable them to be improved and updated with fresh information, enabling them to adjust to new problems and developments in imaging technology.
4. Training and Validation
TensorFlow, Keras, and Python were used to implement the model. A 70:20:10 allocation of the collected dataset from the Kaggle site was employed for the training, validation, and testing. Despite the crucial tactics, early stopping was preferred to avoid overfitting i.e. training was stopped when validation performance plateaued to prevent overfitting. Model checkpointing which ensured the highest validation accuracy was saved for further analysis.
5. Testing and External Validation
To ensure that the model can be used clinically, performance was measured in terms of several critical parameters. It assessed the model’s general performance by calculating the ratio of the correct classifications to all the forecasts made. Specificity focused on the model’s accuracy in identifying healthy patients, while sensitivity (recall) was on the ability of the model to detect tumor-positive instances. This was achieved through calculating the percentage of true positive cases which minimized the false positive rates. Finally, the F1 Score, which computes the harmonic mean of precision and sensitivity, provided a reasonable measure which considers occurrence of false positives and false negatives. Collectively, these measures covered a broad range of aspects that could help evaluate how well the model performs its categorization, which was beneficial for its clinical applicability.
III. Results & Discussion
Convolution feature mapping of different convolution layers from block1 to block5 is depicted in Figure 3. In the first two layers (block1 and block2), there are lesser convolutional operations because these layers are designed to detect simple features such as edges, lines and textures. Hence, conv1 and conv2 were applied to these blocks. These layers extract low-level spatial characteristics so do not need many layer convolutions to have meaningful features. Higher level layers from block3 to block5 have a larger receptive field and consider a larger spatial region in the image for feature extraction. To accomplish this, there must be the use of several than one convolutional layer in a block. As we move deeper layers (block3, block4, block5), the kind of features extracted are much higher level and complex than in the previous layer. That is why these blocks require extra convolutional layers such as conv3, as depicted in the figure. These layers offer higher-level and abstract characteristics that still need additional convolutions (conv3 in this case) in order to refine and obtain significant patterns such as detecting brain tumor spots. The initial layers (block1 and block2) have a smaller receptive field, hence, only a few convolutions are needed to produce representations of these local features. In other words, the need to capture basic features require conv1 and conv2 to be placed at the initial layers (block1 and block2). On the other hand, addition of conv3 to deeper layers (block3, block4, block5) is due to the necessity of the model to capture specific high-level features needed to detect tumors. In this way, this hierarchical feature extraction strategy could be more efficient for MRI data analysis.
The depicted images visualize the first MRI layers compared to the maps created by the model where the bright color denotes areas that the model paid most attention to, which is feature extraction for tumor detection. As for the region slice, consistent activations across multiple slices confirm the model’s ability to identify the locations and sizes of abnormalities in the brain and are consistent with the primary tumor. These visualizations give qualitative assessments about the performance parameters like accuracy, precision, recall, F1-score as well as confirms the effectiveness of the model in which draws attention to the tumor specific regions. Further, the overlays help in understanding the functioning of the CNN to further establish it as a reliable diagnostic model for applications such as medical imaging.
Figure 4(left) depicts the curves of training and validation accuracies of the adapted CNN model over 15 epochs. One can notice that model is learning very quickly from the training data as the training increases sharply to 99 % within the first 5 epochs. The test accuracy also improves gradually and finally stabilizes at 0.95 after 5 epochs. This implies that the model has generalized quite-well. As shown in Figure 4(right), the value of training loss reduces significantly proving that the proposed model is a good fit of the training set. Test loss also reduces however, it appears to level off a bit more than training loss, which is anticipated. This means that although the model has a low-loss on the training data, it might have slightly overfitted the data because the loss on the test data is comparatively higher. On the model performance, the training accuracy as well as the test accuracy are highly converged according to the proposed model. The low-test loss and stable accuracy emphasize that the used CNN-model is capable to make good predictions for unseen MRI scan data for brain tumor prediction.
Receiver Operating Characteristic (ROC) curve illustrated in Figure 5 is a popular method of assessing the efficiency of a binary classifier model. The False Positive Rate indicated at x-axis is defined as the ratio of the number of negative samples that are misclassified as positive to the total number of negative samples. Further, True Positive Rate marked on the y-axis of the model stands for the ratio of positive samples which are accurately predicted as positives. It is also referred to as sensitivity or recall. ROC curve shows the corelation between True Positive Rate and False Positive Rate with varied threshold values.
An ideal classifier is one that will lie closer to the upper left corner which is a true positive rate and a low false positive rate. Diagonal dashed line defines a random classifier, where the true positive rate and false positive rate are equal. This means that the CNN model used in this study for prediction of brain tumors from MRI scans gives very good accuracy with Area Under the Curve (AUC) of almost 1. The model is reliable for the correct classification of MRI images; distinguishing between images with tumor and healthy (without tumor).
A confusion matrix shown in Figure 6 represents the performance of CNN model used for early prediction of brain tumors based on MRI images. There are 428 images for the case of true healthy & predicted healthy indicates healthy patients who were correctly predicted as healthy. This is a true positive for the "Healthy" category. Further, six are the true healthy & predicted unhealthy (tumor) patients who were incorrectly predicted as unhealthy (false positive). In a similar fashion, six true unhealthy & predicted healthy are the unhealthy patients who were incorrectly predicted as healthy (false negative). Altogether, 480 cases of true unhealthy & predicted unhealthy indicates unhealthy patients who were correctly predicted as unhealthy. This is a true positive for the "Unhealthy" category.
In other words, the model has performed well, with a high number of correct predictions like, 428 true healthy and 480 true unhealthy predictions are accurate along with a few misclassifications (6 false positives and 6 false negatives). Based in this analysis, this confusion matrix suggests the model is capable of accurately predicting the presence or absence of brain tumors based on MRI scans, with relatively few misclassifications. The performance can be quantified using metrics like accuracy, precision, recall, and F1 score.
In Figure 7, we have shown the distribution of the classes in the training and test datasets employed for predicting brain tumor. As depicted in Figure 7 (left), it demonstrates the class distribution in training data. The density for healthy samples is ‘0.86’ suggest that training data for the ‘healthy’ class is nearly balanced. However, the unhealthy class is distributed with almost ‘1’ density indicating a uniform distribution in the training data. We have slight variations in the class distributions. However, a balanced distribution is significant in controlling the class imbalance and avoiding any effect on the model’s performance.
Additionally, a similar approach of analyzing class distribution of the test data is also shown in Figure 7 (right). The density for the test data is also near ‘0.88’ for healthy and ‘1’ for unhealthy (tumor) classes. This is of significance because if the model is evaluated with the help of a balanced dataset, the corresponding evaluation measure, including accuracy, precision, recall, and others, will be less prone to reflect one-sided information. If class distribution the training and the test sets both have equal proportions of healthy and unhealthy samples thus it is easy and fair for the model to be trained and tested all through without any prejudicial inclination to any one of the classes. This balance assist in obtaining average performance standards.
We have also plotted the bar chart in Figure 8, which evaluates the model's key performance indicators: Precision, Recall, F1-Score, and Accuracy. As illustrated, accuracy shows the proportion of the correctly predicted instances to total prediction where accuracy equal to ‘0.9’ tends to suggest that the model’s error is extremely low. Hence, the model is effective in predicting the occurrence of brain tumors. The obtained precision indicates that the CNN model yields minimal misclassification of health cases as the brain tumor. Similarly, a high recall demonstrates the model’s capability to identify almost every case of brain tumor thus lowering the chances of missing actual positive cases. F1 Score is nearly ‘0.9’, showing that the model performs well in precision and recall which are inevitable for sensitive applications like brain tumor prediction. Nearly, close to one value presented for all four metrics testifies that CNN model is almost ideal in the early identification of the brain tumor using MRI data. Such results indicate the usefulness of your model in practice and emphasize its potential use as the diagnostic means in medical systems.
IV. Conclusions
We have successfully implemented the CNN model to predict brain tumors from MRI images and obtained high accuracy, precision, and sensitivity. The model was found to be quite robust in locating tumor-specific regions and managing variability of MRI data. Its architecture and performance make it suitable for integration into clinical workflow, particularly, in low resource-constrained environments. Furthermore, this model needs to be refined and most importantly made compatible with medical standards to be applicable in a healthcare systems. Therefore, with further implementation, the proposed CNN model may be helpful to doctors to diagnose early stage of brain tumor and saving the lives of patients.
References
1. Martínez-Del-Río-Ortega, R.; Civit-Masot, J.; Luna-Perejón, F.; Domínguez-Morales, M. Brain Tumor Detection Using Magnetic Resonance Imaging and Convolutional Neural Networks. Big Data Cogn. Comput. 2024, 8, 123. https://doi.org/10.3390/bdcc8090123
2. Aljohani, M., Bahgat, W. M., Balaha, H. M., AbdulAzeem, Y., El-Abd, M., Badawy, M., & Elhosseini, M. A. (2024). An automated metaheuristic-optimized approach for diagnosing and classifying brain tumors based on a convolutional neural network. Results in Engineering, 23(102459), 102459. https://doi.org/10.1016/j.rineng.2024.102459
3. Preetha, R., Priyadarsini, M. J. P., & Nisha, J. S. (2024). Automated brain tumor detection from magnetic resonance images using fine-tuned EfficientNet-B4 convolutional neural network. IEEE Access: Practical Innovations, Open Solutions, 12, 112181–112195. https://doi.org/10.1109/access.2024.3442979
4. Almufareh, M. F., Imran, M., Khan, A., Humayun, M., & Asim, M. (2024). Automated brain tumor segmentation and classification in MRI using YOLO-based deep learning. IEEE Access: Practical Innovations, Open Solutions, 12, 16189–16207. https://doi.org/10.1109/access.2024.3359418
5. Mathivanan, S. K., Sonaimuthu, S., Murugesan, S., Rajadurai, H., Shivahare, B. D., & Shah, M. A. (2024). Employing deep learning and transfer learning for accurate brain tumor detection. Scientific Reports, 14(1), 7232. https://doi.org/10.1038/s41598-024-57970-7
6. A. A. Asiri, T. A. Soomro, A. A. Shah, G. Pogrebna, M. Irfan and S. Alqahtani, "Optimized Brain Tumor Detection: A Dual-Module Approach for MRI Image Enhancement and Tumor Classification," in IEEE Access, vol. 12, pp. 42868-42887, 2024, doi: 10.1109/ACCESS.2024.3379136
7. Aggarwal, M., Tiwari, A. K., Sarathi, M. P., & Bijalwan, A. (2023). An early detection and segmentation of Brain Tumor using Deep Neural Network. BMC Medical Informatics and Decision Making, 23(1), 78. https://doi.org/10.1186/s12911-023-02174-8
8. Sharma, M., & Miglani, N. (2020). Automated brain tumor segmentation in MRI images using deep learning: Overview, challenges and future. In Studies in Big Data (pp. 347–383). Springer International Publishing.
9. Abdusalomov, A. B., Mukhiddinov, M., & Whangbo, T. K. (2023). Brain tumor detection based on deep learning approaches and magnetic resonance imaging. Cancers, 15(16), 4172. https://doi.org/10.3390/cancers15164172
10. Asiri, A. A., Shaf, A., Ali, T., Zafar, M., Pasha, M. A., Irfan, M., Alqahtani, S., Alghamdi, A. J., Alghamdi, A. H., Alshamrani, A. F. A., Aleylyani, M., & Alamri, S. (2023). Enhancing brain tumor diagnosis: Transitioning from convolutional neural network to involutional neural network. IEEE Access: Practical Innovations, Open Solutions, 11, 123080–123095. https://doi.org/10.1109/access.2023.3326421
11. Musallam, A. S. (Ed.). (n.d.). A NewConvolutional Neural Network Architecture for Automatic Detection of Brain Tumors in Magnetic Resonance Imaging Images.
12. Khan, M. S. I., Rahman, A., Debnath, T., Karim, M. R., Nasir, M. K., Band, S. S., Mosavi, A., & Dehzangi, I. (2022). Accurate brain tumor detection using deep convolutional neural network. Computational and Structural Biotechnology Journal, 20, 4733–4745. https://doi.org/10.1016/j.csbj.2022.08.039

, Claims:I. A preprocessing module for image normalization, segmentation, and augmentation;
II. A convolutional neural network (CNN) architecture optimized for feature extraction and classification;
III. A training pipeline with dataset partitioning and hyperparameter tuning;
IV. A visualization module for interpretability and feature localization.
2. The system as claimed in claim 1, wherein the preprocessing module standardizes MRI images to 256 × 256 pixels and normalizes pixel intensity values.
3. The system as claimed in claim 1, wherein the CNN architecture consists of multiple convolutional layers, pooling layers, and fully connected layers for classification.
4. The system as claimed in claim 1, wherein data augmentation techniques, including flipping, rotation, and brightness modulation, enhance model generalization.
5. The system as claimed in claim 1, wherein the training pipeline includes early stopping mechanisms to prevent overfitting.
6. The system as claimed in claim 1, wherein performance evaluation metrics include ROC curves, confusion matrices, and F1-score assessments.
7. The system as claimed in claim 1, wherein feature visualization techniques such as heatmaps and Grad-CAM improve model interpretability.
8. The system as claimed in claim 1, wherein the system supports real-time clinical applications with minimal computational overhead.
9. The system as claimed in claim 1, wherein interoperability features enable seamless integration with hospital information systems (HIS) and PACS.
10. The system as claimed in claim 1, wherein the model is designed for deployment in both high-resource and low-resource medical environments